methylxanthine

Overview

Methylxanthines are a class of naturally occurring purine alkaloids derived from xanthine, characterized by one or more methyl groups attached to the xanthine scaffold. The most pharmacologically prominent members include caffeine (1,3,7-trimethylxanthine), theobromine (3,7-dimethylxanthine), and theophylline (1,3-dimethylxanthine). These compounds are ubiquitous in widely consumed plant-derived foods and beverages — notably coffee, tea, cocoa (Theobroma cacao), and yerba maté — and have been subjects of sustained scientific interest for their diverse biological activities. Mechanistically, methylxanthines act primarily as competitive antagonists of adenosine receptors (A1 and A2A subtypes), thereby exerting stimulatory effects on the central nervous system, cardiovascular system, and smooth muscle. They also inhibit phosphodiesterase enzymes at higher concentrations, elevating intracellular cyclic AMP levels, and have been associated with modulation of inflammatory signaling pathways involving nuclear factor kappa B and downstream cytokines such as interleukin-6 and C-C motif chemokine ligand 2.

Beyond their stimulant properties, methylxanthines — and caffeine in particular — serve extensively as model compounds in pharmaceutical science due to their well-characterized physicochemical profiles, moderate aqueous solubility, and predictable membrane permeability. Their antioxidant and cardioprotective properties, often studied alongside (poly)phenols and compounds such as 3,4-dihydroxybenzoic acid, render them relevant to nutritional biochemistry and functional food research. Theobromine has additionally attracted interest for its remineralizing potential in dentistry and its comparatively mild stimulatory profile relative to caffeine. The dual relevance of methylxanthines to pharmaceutical formulation science and food bioactivity research makes them among the most broadly studied small-molecule bioactive compounds in the literature.

Focus of Latest Publications

Recent studies used methylxanthines primarily as analytical targets, model compounds, or bioactive constituents in food and environmental matrices.

Several publications focused on caffeine as a model drug in pharmaceutical development. One study on twin-screw melt granulation used caffeine mixed with mannitol (Parteck® M100) and processed with a Pharma 11 extruder to produce high-drug-loaded immediate-release tablets. This work positioned caffeine as a practical model for evaluating granulation behavior and tablet performance in immediate and sustained drug release systems. Another pharmaceutics study used caffeine in a dissolution-permeation apparatus to demonstrate membrane transport under controlled hydrodynamic conditions, supporting its use as a model solute for permeability testing. A separate study on sublingual absorption compared caffeine with other model drugs after administration of orally disintegrating tablets and oral tablets, showing its utility in empirical absorption studies.

In nutrition and food science, methylxanthines were examined as naturally occurring constituents of beverages and plant extracts. A study on commercial green coffee bean extract supplements assessed chlorogenic acids and caffeine content, highlighting their importance in product quality and mislabelling detection. Another study on Longjing green tea found that baking reduced polyphenols, Amino Acids, and soluble sugars, while caffeine levels remained relatively stable across baking durations. Cocoa research also emphasized methylxanthines, specifically theobromine and caffeine, as major bioactive compounds with stimulant, antioxidant, and cardioprotective properties; simulated gastrointestinal digestion using INFOGEST 2.0 was used to evaluate methylxanthine bioaccessibility and antioxidant properties. Coffee pulp extract research similarly reported elevated caffeine concentrations in EtOH-modified supercritical-CO2 digesta, alongside protocatechuic acid, with associated ABTS radical scavenging capacity, cellular antioxidant activity, and cyclooxygenase 2 inhibition. These findings place methylxanthines in the broader context of food-derived bioactives interacting with (poly)phenols and oxidative stress pathways.

Methylxanthines also appeared in studies of human exposure and physiology. Moderate coffee intake, corresponding to approximately 95 to 100 mg caffeine, did not significantly alter short-term bioelectrical impedance measurements in healthy women under controlled conditions. This suggests that moderate caffeine intake does not acutely confound body composition assessment by bioelectrical impedance analysis or the InBody 270 system. Such work is relevant to clinical and nutritional interpretation of caffeine exposure in healthy adults.

Environmental studies treated caffeine and its Metabolites as important micropollutants and indicators of pharmaceutical contamination. In surface waters of a tropical agro-livestock region of Costa Rica, caffeine was among the compounds categorized as high-risk to aquatic life based on hazard quotient analysis. In the Pearl River Basin, caffeine was one of the most ubiquitous pharmaceutically active compounds detected. Another environmental survey in the eThekwini catchment reported high concentrations of 1,7-dimethylxanthine, a caffeine metabolite, in influents and effluents, underscoring the persistence of methylxanthine-related compounds in wastewater systems. An ecotoxicological assessment involving Zantedeschia aethiopica and Eisenia foetida also included caffeine among pseudo-persistent contaminants associated with chronic toxicity concerns in biofilters and related matrices.

Although not all studies centered on methylxanthines directly, one oral health investigation evaluated propolis, chitosan, and theobromine for remineralisation and antibacterial/anti-biofilm activity against artificial initial carious lesions. This reinforces the biomedical interest in methylxanthines beyond stimulation, extending to dental and antimicrobial applications.

Key Publications

• NEWJun Impact of Interactions between Melanoidins and Caffeine on the Bitter Taste of Coffee Beverages. (Journal of agricultural and food chemistry, 2026, PMID 42234800): "Since the discovery of caffeine in 1819 by Runge, its role in the sensory perception of coffee remains unclear."
• Jun Spatial occurrence and distribution of micropollutants (pharmaceuticals and personal care products) in the eThekwini catchment, South Africa. (Environmental pollution (Barking, Essex : 1987), 2026, PMID 41985610): "The highest concentrations in the influents and effluents were observed for 1,7-dimethylxanthine (a metabolite of caffeine), with mean concentrations of 723 668.4 ± 180 002.5 ng L-1 and 409 405.7 ± 173 761.3 ng L-1, respectively."
• Jun Occurrence, spatiotemporal distribution, and potential toxicity analysis of pharmaceutically active compounds in the Pearl River Basin. (Environmental pollution (Barking, Essex : 1987), 2026, PMID 42025674): "Caffeine, cimetidine, and acetaminophen were the most ubiquitous compounds in the studied region."
• Jun Twin-Screw Melt Granulation with Mannitol: High-Drug-Loaded Immediate-Release Tablets of Caffeine. (AAPS PharmSciTech, 2026, PMID 42286306): "Model drug caffeine was mixed with mannitol (Parteck® M100), while a Pharma 11 extruder with helix feed screw elements and without a nozzle was used for twin-screw melt granulation."
• Jun Design and application of a dissolution-permeation apparatus with scalable surface area and controllable hydrodynamic conditions at the membrane interface. (European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2026, PMID 41980673): "The functionality of the apparatus was demonstrated using carboxyfluorescein and caffeine as model solutes permeating across polycarbonate and polyvinylidene fluoride membranes under varying hydrodynamic conditions."
• Jun Moderate coffee intake does not significantly affect short-term bioelectrical impedance measurements in healthy women. (Nutrition research (New York, N.Y.), 2026, PMID 42102665): "Under controlled conditions, moderate caffeine intake (∼95 to 100 mg) or 200 mL fluid volume does not induce significant short-term alterations in BIA-derived body composition in healthy women."
• May Evaluation of the Remineralisation and Antibacterial Properties of Propolis, Chitosan, and Theobromine. (Oral health & preventive dentistry, 2026, PMID 42205106): "This study evaluated the remineralisation potential of the natural compounds propolis, chitosan, and theobromine on artificial initial carious lesions and investigated their antibacterial and anti-biofilm activities."
• May Chlorogenic acids and caffeine in commercial green coffee bean extract supplements: quantitative assessment and evidence of mislabelling. (Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment, 2026, PMID 42154619): "...primarily due to their chlorogenic acids (CGAs) and caffeine content."
• May Ecotoxicological assessment of Zantedeschia aethiopica (L.) and Eisenia foetida Savigny exposure to pharmaceutical and personal care products, and hazelnut shell. (The Science of the total environment, 2026, PMID 41965162): "Caffeine, ibuprofen, losartan, and triclosan are pseudo persistent contaminants, generating chronic toxicity, and hydrolysis of organic support as porous media could cause effects on biotic components (plants and earthworms) of biofilters."
• May Environmental risk profiling of pharmaceuticals in surface waters in a tropical agro-livestock region of Costa Rica. (Environmental monitoring and assessment, 2026, PMID 42118225): "The risk assessment identified that 10 of the 15 detected pharmaceuticals posed a moderate to high chronic risk to aquatic life; specifically, sulfathiazole, clarithromycin, caffeine, and ofloxacin were categorized as high-risk compounds (HQ > 1)."